Open | $0.910 |
Close | $0.900 |
Volume / Avg. | 370.010K / 368.638K |
Day Range | 0.878 - 0.911 |
52 Wk Range | 0.458 - 1.480 |
Market Cap | $54.064M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 0.62% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Homology Medicines (NASDAQ: FIXX) through any online brokerage.
Other companies in Homology Medicines’s space includes: Curis (NASDAQ:CRIS), Immuneering (NASDAQ:IMRX), Elicio Therapeutics (NASDAQ:ELTX), CollPlant Biotechnologies (NASDAQ:CLGN) and vTv Therapeutics (NASDAQ:VTVT).
The latest price target for Homology Medicines (NASDAQ: FIXX) was reported by Baird on Friday, July 28, 2023. The analyst firm set a price target for 1.50 expecting FIXX to rise to within 12 months (a possible 61.29% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Homology Medicines (NASDAQ: FIXX) is $0.93 last updated March 18, 2024 at 6:11 PM EDT.
There are no upcoming dividends for Homology Medicines.
Homology Medicines’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Homology Medicines.
Homology Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.